Target 9: Provide essential medicines to treat NCDs
Target 9 - An 80% availability of the affordable basic technologies and essential medicines, including generics, required to treat major NCDs in both public and private facilities
WHO model list of essential medicines
Global status report on noncommunicable diseases 2010
Scaling up action against NCDs: How much will it cost?
Service availability and readiness assessment (SARA)
- WHO guidance on ensuring balance in national policies on controlled substances
- WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses